Mineralys reports positive data from trial of lorundrostat for hypertension

Mineralys reports positive data from trial of lorundrostat for hypertension

Source: 
Clinical Trials Arena
snippet: 

Mineralys Therapeutics has reported positive results from the Target-HTN Phase II clinical trial of lorundrostat to treat uncontrolled and resistant hypertension.